arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Scienture Holdings, Inc.

SCNX
$0.37 0.00 (-0.08%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
54 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Scienture Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $15.0M
Dividend Yield
Revenue Growth 449.1%
Op. Margin None
ROIC -4.1%
FCF / Share $-0.07
Trailing P/E
Price / Book 0.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

54-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$56.33K
↑ +449.1%
Net Income Profit after all expenses
$-3.40M
↓ -11.0%
Operating Margin Operating profit as % of sales
-41.1%
↓ -167.5%
FCF / Share Free cash flow per share
$-0.07
↑ +77.1%
Long-Term Debt Long-term obligations
$2.00M
↓ -44.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
14
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters